| |
| |
|
| Insider
Information: |
Fardis Maria |
| Relationship: |
President and CEO, Dir... |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
301,979 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,059,569 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
301,979 |
|
|
| Total
Value |
$3,059,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
Chief of Oncology Ops ... |
2014-11-13 |
3,193 |
|
0 |
Premium* |
|
|
Iovance Biotherapeutics Inc |
IOVA |
President and CEO, Dir... |
2020-06-01 |
298,786 |
2016-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
EVP, Operations and Alliances |
• – – |
2013-01-08 |
4 |
S |
$65.00 |
$162,500 |
D/D |
(2,500) |
976 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2013-04-30 |
4 |
A |
$10.56 |
$21,241 |
D/D |
2,012 |
2,988 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
S |
$140.50 |
$421,504 |
D/D |
(3,000) |
2,988 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
EVP, Operations and AlliancesO |
• – – |
2012-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,149 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
3,192 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-08-13 |
4 |
S |
$121.01 |
$484,040 |
D/D |
(4,000) |
3,192 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-10-31 |
4 |
A |
$80.93 |
$81 |
D/D |
1 |
3,193 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-11-07 |
4 |
S |
$134.50 |
$672,500 |
D/D |
(5,000) |
3,193 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-11-13 |
4 |
S |
$141.30 |
$423,902 |
D/D |
(3,000) |
3,193 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
EVP, Operations and Alliances |
• – – |
2012-10-31 |
4 |
A |
$10.56 |
$3,452 |
D/D |
327 |
3,476 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
EVP, Operations and Alliances |
• – – |
2013-01-07 |
4 |
S |
$64.20 |
$224,700 |
D/D |
(3,500) |
3,476 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
OE |
$6.84 |
$20,520 |
D/D |
3,000 |
5,988 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-11-13 |
4 |
OE |
$6.84 |
$20,520 |
D/D |
3,000 |
6,193 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
EVP, Operations and Alliances |
• – – |
2013-01-07 |
4 |
OE |
$6.84 |
$23,940 |
D/D |
3,500 |
6,976 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-08-13 |
4 |
OE |
$6.84 |
$27,360 |
D/D |
4,000 |
7,192 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-11-07 |
4 |
OE |
$6.84 |
$34,200 |
D/D |
5,000 |
8,193 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2020-06-01 |
4 |
D |
$33.12 |
$62,729 |
D/D |
(1,894) |
298,786 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2020-05-01 |
4 |
D |
$32.00 |
$60,608 |
D/D |
(1,894) |
300,680 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2020-04-01 |
4 |
D |
$27.94 |
$41,742 |
D/D |
(1,494) |
302,574 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2020-03-02 |
4 |
D |
$35.99 |
$47,543 |
D/D |
(1,321) |
304,068 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2020-02-03 |
4 |
D |
$22.54 |
$29,347 |
D/D |
(1,302) |
305,389 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2020-01-02 |
4 |
D |
$26.68 |
$41,674 |
D/D |
(1,562) |
306,691 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-12-02 |
4 |
D |
$22.66 |
$42,918 |
D/D |
(1,894) |
308,253 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-11-01 |
4 |
D |
$21.97 |
$41,611 |
D/D |
(1,894) |
310,147 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-10-01 |
4 |
D |
$18.21 |
$34,490 |
D/D |
(1,894) |
312,041 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
